$OSTX
1 catalyst touching OSTX in the last 60 days, newest first, each with the price move that followed.
- 45
OSTX appoints Frank Knuettel II as CFO, Kerry Clem as Chief Commercial Officer
OS Therapies announced the effective September 29, 2026 appointment of Frank Knuettel II as CFO (replacing Christopher P. Acevedo, who will consult) and Kerry Clem as Chief Commercial Officer. Knuettel brings three decades of experience in life sciences and technology, including prior roles as CEO/CFO at Channel Therapeutics and Pelthos, and has experience with M&A and capital raises. While a CFO change can signal strategic shifts, the filing does not disclose any sudden departure or crisis—Acevedo transitions to consulting—making this a routine executive appointment rather than a material eve
OSTX ·SEC 8-K · 5 Oct 2026, 20:37 UTC
Information only. AURA does not give buy or sell recommendations.